Literature DB >> 10529004

Estradiol induction of cAMP in breast cancer cells is mediated by foetal calf serum (FCS) and sex hormone-binding globulin (SHBG).

N Fortunati1, F Fissore, A Fazzari, F Piovano, M G Catalano, M Becchis, L Berta, R Frairia.   

Abstract

Plasma sex hormone-binding globulin (SHBG or SBP), the specific carrier for estradiol and androgens, after binding to its membrane receptor (SHBG-R), causes a significant increase of cAMP in the presence of estradiol, in both breast (MCF-7) and prostate (LNCaP) cancer cells maintained in serum-free medium. On the other hand, it has been proposed that estrogens, in addition to the well-known nuclear receptor pathway, exert their biological effect inducing cAMP, as a consequence of a direct membrane action, in breast cancer and uterine cells. The aim of the present study was to clarify this controversial issue by verifying if the cAMP increase in MCF-7 cells was a direct effect of estradiol, or if it was mediated by FCS proteins, such as bovine sex hormone-binding globulin; and to reevaluate the effect of human SHBG on cAMP induction in the presence of FCS. MCF-7 cells were maintained in DCC-FCS (treated with DCC to remove steroids), in SHBG-FREE/DCC-FCS (treated with DCC and with a specific affinity chromatography to remove bovine sex hormone-binding globulin), or in serum-free medium (SFM). It was observed that estradiol determined a significant time-dependent increase of cAMP only in MCF-7 cells maintained in 10% DCC-FCS. When cells were maintained in 10% SHBG-FREE/DCC-FCS, estradiol had no detectable effect. However, its ability to increase cAMP was observed again after the addition of human SHBG, in doses ranging from 5 to 50 nM. Moreover, in the presence of 10% SHBG-FREE/DCC-FCS, SHBG, even in the absence of estradiol, caused a significant increase of cAMP. In conclusion, the data reported in the present study suggest that the ability of estradiol to induce cAMP in MCF-7 cells is not due to a direct membrane effect of the hormone, but rather it is mediated by FCS. SHBG is one of the serum factors mediating estradiol action. Lastly, it was proven that SHBG triggers the cAMP pathway in MCF-7 cells in a physiologic culture condition and at physiologic concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529004     DOI: 10.1016/s0960-0760(99)00092-8

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  9 in total

Review 1.  Sex hormone-binding globulin: not only a transport protein. What news is around the corner?

Authors:  N Fortunati
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

2.  SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV.

Authors:  Jenny Pena Dias; Damani A Piggott; Jing Sun; Leen Wehbeh; Joshua Garza; Alison Abraham; Jacquie Astemborski; Kendall F Moseley; Shehzad Basaria; Ravi Varadhan; Todd T Brown
Journal:  J Clin Endocrinol Metab       Date:  2022-06-16       Impact factor: 6.134

3.  Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women.

Authors:  Mellissa Yong; Charlotte Atkinson; Katherine M Newton; Erin J Aiello Bowles; Frank Z Stanczyk; Kim C Westerlind; Victoria L Holt; Stephen M Schwartz; Wendy M Leisenring; Johanna W Lampe
Journal:  Cancer Causes Control       Date:  2009-03-12       Impact factor: 2.506

4.  Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses.

Authors:  Dragoslava Zivadinovic; Bahiru Gametchu; Cheryl S Watson
Journal:  Breast Cancer Res       Date:  2004-11-24       Impact factor: 6.466

5.  The association of breast mitogens with mammographic densities.

Authors:  N F Boyd; J Stone; L J Martin; R Jong; E Fishell; M Yaffe; G Hammond; S Minkin
Journal:  Br J Cancer       Date:  2002-10-07       Impact factor: 7.640

6.  Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations.

Authors:  Ruixia Huang; Yuanyuan Ma; Ruth Holm; Claes G Trope; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2013-12-26       Impact factor: 3.240

7.  Sex hormone-binding globulin provides a novel entry pathway for estradiol and influences subsequent signaling in lymphocytes via membrane receptor.

Authors:  Andrea Balogh; Eva Karpati; Andrea E Schneider; Szabolcs Hetey; Andras Szilagyi; Kata Juhasz; Gloria Laszlo; Petronella Hupuczi; Peter Zavodszky; Zoltan Papp; Janos Matko; Nandor Gabor Than
Journal:  Sci Rep       Date:  2019-01-09       Impact factor: 4.379

8.  Total testosterone is not associated with lean mass or handgrip strength in pre-menopausal females.

Authors:  Jill A Hnatiuk; Séverine Lamon; Sarah E Alexander; Gavin Abbott; Brad Aisbett; Glenn D Wadley
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  SHBG is an important factor in stemness induction of cells by DHT in vitro and associated with poor clinical features of prostate carcinomas.

Authors:  Yuanyuan Ma; Dongming Liang; Jian Liu; Jian-Guo Wen; Einar Servoll; Gudmund Waaler; Thorstein Sæter; Karol Axcrona; Ljiljana Vlatkovic; Ulrika Axcrona; Elisabeth Paus; Yue Yang; Zhiqian Zhang; Gunnar Kvalheim; Jahn M Nesland; Zhenhe Suo
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.